Loading clinical trials...

Clinical Utility of Rapid CT/NG Testing in the ED | Clinical Trials | Clareo Health

COMPLETEDNA

Clinical Utility of Rapid CT/NG Testing in the ED

NCT02200224•Johns Hopkins University

Summary

The purpose of this study is to: 1. determine the clinical impact of rapid Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG) testing on antibiotic over and under treatment for CT/NG in women evaluated in the Emergency Department (ED) for a Sexually Transmitted Infection (STI). 2. determine the clinical impact of rapid Trichomonas Vaginalis (TV) testing on antibiotic under and over treatment for TV in women evaluated in the ED for an STI 3. evaluate the feasibility of integrating rapid Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG) and TV testing in the Emergency Department setting. To evaluate the impact or rapid CT/NG/TV testing an patient comprehension of Sexually Transmitted Infection diagnosis.

Eligibility

Age

18 - 50 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•The study population includes women between the age of 18 and 50 who present to the ED and are going to receive CT/NG testing in the ED.

Exclusion Criteria

•Patients will be excluded if they are unable to provide informed consent or are not English speaking.

Locations (1)

Johns Hopkins Hospital

Baltimore, Maryland, United States

Key Dates

Start Date

April 1, 2015

Primary Completion Date

May 1, 2016

Completion Date

May 1, 2016

Last Updated

May 9, 2016

Enrollment

300

ACTUAL participants

Conditions

Sexually Transmitted Diseases

Interventions

Rapid Testing

OTHER

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing

NCT07072481

HIV/AIDSSexually Transmitted Diseases

View study

RECRUITINGNA

Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)

NCT06579781

Sexual BehaviorAdolescent Behavior+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 9, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinical Utility of Rapid CT/NG Testing in the ED

Inclusion Criteria

Exclusion Criteria

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing

Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)

Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM

Pharmacokinetic Characterization of a Single 200 mg Dose of Doxycycline in Post-exposure Prophylaxis (PEP) of Sexually Transmitted Infections in Different Biological Compartments

Doxycycline Intervention for Bacterial STI ChemoprOphylaxis (DISCO)

Vienna HIV Infection Via Sex Study